» Articles » PMID: 15598424

PD-1 Ligands, Negative Regulators for Activation of Naive, Memory, and Recently Activated Human CD4+ T Cells

Overview
Journal Cell Immunol
Publisher Elsevier
Date 2004 Dec 16
PMID 15598424
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the role of the PD-1 pathway on the activation of naive, memory, and recently activated human CD4+ T cells to test whether they responded differently. PD-1 ligand blockade modestly enhanced the percentage of responding T cells and production of IFN-gamma in a primary response to myelin basic protein (MBP) in normal donors. PD-1 ligand blockade strongly enhanced proliferation and cytokine production by memory or recently activated T cells (tetanus toxoid and MBP). Blockade of PD-L1 alone had more effect than PD-L2, consistent with its higher expression on ex vivo dendritic cells; furthermore, anti-PD-L1 plus anti-PD-L2 resulted in the greatest enhancement. Moreover, PD-L1-Ig inhibited anti-CD3 induced activation of naive, memory, and recently activated CD4+ T cells. Together, our data demonstrated PD-1 functioned as a negative regulatory pathway on naive T cells during a primary response, and more potently, on memory or recently activated T cells during a secondary response.

Citing Articles

Evaluation of Immune Exhaustion and Co-Inhibitory Receptor Expression in Subspecies (MAP) Seropositive Diarrhoeic Bovines.

Sharma S, Sharma K, Kumar R, Dayal D, Dhanda S, Kumar N Pathogens. 2024; 13(6).

PMID: 38921771 PMC: 11206971. DOI: 10.3390/pathogens13060473.


The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth.

Xu F, Sun H, Fang R, Zhang L, Shi H, Wang X Acta Pharmacol Sin. 2021; 43(2):429-445.

PMID: 33824459 PMC: 8791967. DOI: 10.1038/s41401-021-00631-6.


Emerging Landscapes of Tumor Immunity and Metabolism.

Wu F, Cheng Y, Wu L, Zhang W, Zheng W, Wang Q Front Oncol. 2020; 10:575037.

PMID: 33117713 PMC: 7575711. DOI: 10.3389/fonc.2020.575037.


Aspirin-targeted PD-L1 in lung cancer growth inhibition.

Zhang Y, Lv C, Dong Y, Yang Q Thorac Cancer. 2020; 11(6):1587-1593.

PMID: 32297484 PMC: 7262895. DOI: 10.1111/1759-7714.13433.


Circulating PD-1CXCR5CD4 T cells underlying the immunological mechanisms of IgG4-related disease.

Kamekura R, Yamamoto M, Takano K, Yabe H, Ito F, Ikegami I Rheumatol Adv Pract. 2019; 2(2):rky043.

PMID: 31431980 PMC: 6649940. DOI: 10.1093/rap/rky043.